Developing a vaccine to stimulate immune responses against HIV
Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization
This study is working on a new vaccine for HIV-1 that aims to help your body produce strong antibodies to fight the virus, using special techniques in mice that are designed to act like humans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11063964 on NIH RePORTER |
What this research studies
This research aims to create an effective vaccine for HIV-1 by eliciting diverse immune responses, particularly focusing on broadly neutralizing antibodies (bnAbs) that target the CD4-binding site. The approach involves a series of immunizations using specially designed Env-derived immunogens to guide the maturation of these antibodies. By using transgenic mice that better mimic human immune responses, the researchers hope to optimize the immunization process to enhance the effectiveness of the antibodies produced. This innovative method seeks to improve the neutralizing capacity of the antibodies against various strains of the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals at high risk for HIV infection or those interested in participating in vaccine trials.
Not a fit: Patients who are already HIV-positive or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking HIV vaccine that provides broader protection against the virus.
How similar studies have performed: Previous research has shown promise in similar approaches to developing HIV vaccines, indicating potential for success in this novel strategy.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Stamatatos, Leonidas — Fred Hutchinson Cancer Center
- Study coordinator: Stamatatos, Leonidas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.